Findings validate and support the use of the PARDI-AR-Q for assessing ARFID symptoms in Turkish adolescents, indicating further clinical applications.
These findings demonstrate that the Turkish version of the PARDI-AR-Q is a reliable and valid instrument for assessing ARFID symptoms in community samples of Turkish adolescents. The Turkish version of the PARDI-AR-Q may contribute to the identification of ARFID-related symptom patterns in adolescents; however, its clinical utility for early detection should be further established through studies conducted in clinical samples using diagnostic interviews.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: